Clinical Trial Update: Efficacy and Safety of Passiflora Incarnata and Isoflavona Combination in the Treatment of Climacteric Symptoms [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating a Passiflora incarnata and Isoflavona combination for climacteric symptoms has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Climacteric Syndrome

Drugs mentioned

• Isoflavona (isoflavone preparation)
• Passiflora incarnata (Passiflora incarnata)

Snippet

Sponsor: Ache Laboratorios Farmaceuticos S.A. | Conditions: Climacteric Syndrome | Phase 3 | Status: WITHDRAWN